Ms. Lana Culley reports

AURORA ANNOUNCES MEDICAL PRODUCT ADVANCEMENTS FROM LEADING CANNABIS RESEARCH FACILITY; CANADA'S LARGEST MEDICAL CANNABIS COMPANY CONTINUES TO OFFER GREATER CHOICE FOR PATIENTS

Aurora Cannabis Inc. has made developments in cannabis science from Aurora's world-class research and genetics facility, Aurora Coast. With a continued focus on premium, science-driven insights, these latest innovations demonstrate Aurora's commitment to providing patients with continuing access to superior product offerings on its AuroraMedical website.

"As a company committed to leading the way in terms of cannabis innovation, we are dedicated to putting patients first by harnessing the innovative solutions developed by our top researchers at Aurora Coast, our unique global research facility," said Lana Culley, vice-president, science and innovation, at Aurora. "We strive to continuously raise the bar on product superiority and overall user experience so that we can deliver on our mission of providing patients with access to the very best medical cannabis."

The latest innovations include:

• Aurora | CBD Varius (one gram, 510 cartridge); a smooth and refined option for patients;

• MedReleaf (Strains for Heroes) | Esprit de Corps (five g and 15 g); a premium sativa (THC: 20 to 29 per cent, CBD: 0 to one per cent), developed under the Strains for Heroes initiative by Aurora with direct feedback from veteran patients;

• MedReleaf | Sedamen (one g, 510 cartridge); a patient-favourite in a higher THC, larger format;

• MedReleaf | Noculus (five g and 15 g); an ultrahigh-potency indica, boasting THC levels between 25 and 31 per cent and CBD content from 0 to 1 per cent;

• WMMC | Seasonal Stash -- Frosted Alpine (10 g); a limited grown hybrid strain (THC: 24-30 per cent; CBD: 0 to 1 per cent).

Aurora's world-class research and development facility, Aurora Coast, located in Comox, on Vancouver Island, is home to some of the most advanced cannabis research and genetics discovery work worldwide. New cultivars developed at Aurora Coast are subsequently grown across Aurora's Canadian cultivation network where the company adheres to the highest production practices at its EU-GMP and TGA-GMP certified facilities. Aurora partners with several other licensed producers who have licences to grow its cultivars creating more value for both Aurora and the broader industry.

Aurora's industry-leading portfolio of medical cannabis products is available on-line via Aurora's comprehensive medical patient platform at AuroraMedical. Patients can access a wide range of innovative, high-quality products tailored to meet their needs.

About Aurora Cannabis Inc.

Aurora is opening the world to cannabis, serving both the medical and consumer markets across Canada, Europe, Australia and South America. Headquartered in Edmonton, Aurora is a pioneer in global cannabis, dedicated to helping people improve their lives. The company's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co., as well as international brands, Pedanios, Bidiol, IndiMed and CraftPlant. Aurora also has a controlling interest in Bevo Farms Ltd., North America's leading supplier of propagated agricultural plants. Driven by science and innovation, and with a focus on high-quality cannabis products, Aurora's brands continue to break through as industry leaders in the medical, wellness and adult recreational markets wherever they are launched.

We seek Safe Harbor.